MicroRNA‐140‐5p elevates cerebral protection of dexmedetomidine against hypoxic–ischaemic brain damage via the Wnt/β‐catenin signalling pathway

Hypoxia–ischaemia (HI) remains a major cause of foetal brain damage presented a scarcity of effective therapeutic approaches. Dexmedetomidine (DEX) and microRNA‐140‐5p (miR‐140‐5p) have been highlighted due to its potentially significant role in the treatment of cerebral ischaemia. This study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xin‐Rui, Wen, Xin, Wang, Yong‐Jian, Wang, Shan, Shen, Min, Zhang, Zi‐Feng, Fan, Shao‐Hua, Shan, Qun, Wang, Liang, Li, Meng‐Qiu, Hu, Bin, Sun, Chun‐Hui, Wu, Dong‐Mei, Lu, Jun, Zheng, Yuan‐Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980153/
https://www.ncbi.nlm.nih.gov/pubmed/29536658
http://dx.doi.org/10.1111/jcmm.13597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980153/
https://www.ncbi.nlm.nih.gov/pubmed/29536658
http://dx.doi.org/10.1111/jcmm.13597

Ejemplares similares